Google+

June 6-9, 2016 | San Francisco, CA

Double Helix Sponsor

loading...

Schedule at a glance

Register Now

 

 

BIO Buzz - Official Show Daily, Brought to you by Alexandria

Health Care

Videos

Dave Thomas, Senior Director of Industry Research and Policy Analysis, BIO. BIO Buzz Center 2015
Pamela Gavin, COO, National Organization for Rare Disorders at the BIO Buzz Center 2015
Dr. Eric Topol, Director, Scripps Translational Science Institute, at the BIO Buzz Center 2015
Paul Hastings, OncoMed Pharmaceuticals at the 2015 BIO International Convention
Seema Kumar, Johnson & Johnson at the 2015 BIO International Convention
Dr. Barry Springer, VP of Strategy, Janssen BioTherapeutics, at the BIO Buzz Center 2015
Kimberly Wintenberg, Advanced Plasma Products at the 2015 BIO International Convention
Dr. Francis Kateh, Deputy Minister of Health & CMO, Liberia, at the BIO Buzz Center 2015
Marc Boutin, National Health Council at the 2015 BIO International Convention
Ted Buckley, Head of Government Relations and Public Affairs, Shire Pharmaceuticals
Dr. John Watson, UK Department of Health at the 2015 BIO International Convention
Dr. Robin Robinson, BARDA at the 2015 BIO International Convention

Articles from BioTechNow

Rx Response Changes Name to Healthcare Ready

Publish Date: 8/12/2015, Created By: Tracy Cooley


Yesterday, Rx Response announced that its name will be changing to Healthcare Ready. For nearly nine years, Rx Response has helped protect patients’ continued access to medicines in more than 55 different disasters. The rationale for the name change is to better reflect its shifting mission of providing assistance in areas of healthcare outside of medicines and pharmacy. The group has gained significant experience and expertise in ‘coordinating the healthcare system and the public sector during disasters, ...

Read More >

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

Publish Date: 6/18/2015, Created By: BIOtechNOW Editor


In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for ...

Read More >

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Publish Date: 6/18/2015, Created By: BIOtechNOW Editor


Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but ...

Read More >

Wednesday Recap of BIO 2015: What the Official Bloggers Have to Say

Publish Date: 6/17/2015, Created By: Kathryn Mueller


Everyday our BIO Official Bloggers, writers who are on top of the biotechnology beat, release statements about their experience at the BIO International Convention. Here is what they want to share with you today: Scrip Intelligence By Lisa LaMotta Roche’s strong deal-making position is at least partly due to its acquisition of Genentech, but partnering head Sophie Kornowski-Bonnet explained that the firm is more interested in looking for drugs than bolt-on companies. Read more…   ...

Read More >

Dr. Eric Topol’s Insights on Wearables, Smart Phones, Digital Medicine Revolution

Publish Date: 6/17/2015, Created By: Tracy Cooley


Dr. Eric Topol, director of the Scripps Translational Science Institute, is widely recognized for many things: as a renowned cardiologist, #1 Most Influential Physician Executive in the United States by Modern Healthcare, “Rock Star of Science” by GQ, author of several books, and the top authority on digital medicine, but who knew he was also a comedian? Topol shared his views with the BIO 2015 keynote luncheon audience in an informative and humorous way. Using videos ...

Read More >

The Future of Health and Medicine in the Digital Era

Publish Date: 6/17/2015, Created By: Caitlin Kennedy


Dr. Daniel Kraft is a well-known Stanford and Harvard trained physician-scientist and innovator with over 20 years of clinical, research and innovation experience. He serves as Faculty chair for Medicine at Singularity University and is the Founder and Executive Director of Exponential Medicine. Dr. Kraft concluded the Digital Health Forum with his session titled The Future of Health and Medicine: Where Can Technology Take Us? which offered a fast-paced look at the next few years of innovations in ...

Read More >

Complexities of Rare Diseases Take the Spotlight at BIO

Publish Date: 6/17/2015, Created By: Tracy Cooley


Global Genes Founder & CEO Nicole Boice opened the BIO 2015 Orphan & Rare Disease Track by addressing a packed session with a simple, powerful statement: “We’re all working to eliminate the challenges of rare diseases, but patients and their advocates aren’t always equipped to fight.” Organizations like Global Genes help families affected by rare disease by connecting them with much needed tools and resources. By better understanding the definition of a “rare” disease, industry ...

Read More >

Outdated Payments Systems Aren’t Keeping Pace With Medical Innovation

Publish Date: 6/17/2015, Created By: Tracy Cooley


We are experiencing an era of rapid medical progress thanks to the accelerated pace at which new breakthroughs are being uncovered. The compression in time between research and the creation of new treatments is a triumph for patients but a challenge for our outdated healthcare delivery system. Our payment systems were constructed to finance medical costs that increased at predictable rates but are now outdated because of the breakthrough medical advances constantly being made. The ...

Read More >

Expanding the Role of Patients in Drug Development

Publish Date: 6/17/2015, Created By: Tracy Cooley


Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to play a critical role in the search for treatments and cures for chronic and deadly diseases.  As part of the 5th authorization of the Prescription Drug User Fee Act (PDUFA V), the Food and Drug Administration made a commitment to more systematically gather patients’ perspectives on their condition and the available therapies in order to incorporate these findings into their ...

Read More >

BIO 2015 Kicks Off: Patient-Focused Drug Development Key Theme of Day One

Publish Date: 6/16/2015, Created By: Tracy Cooley


The BIO International Convention kicked off in Philadelphia today with a strong emphasis on patient-focused drug development as a seismic shift in the way drugs are developed and delivered. The luncheon keynote featured a discussion with News Anchor and Journalist Tom Brokaw interviewed by BIO’s Jim Greenwood, in which Brokaw shared his experience and perspective as a patient. Brokaw recently authored a book about his experiences as a Multiple Myeloma patient – A Lucky Life Interrupted. ...

Read More >

Thank you to our 2015 Sponsors

Double Helix Sponsors

Helix Sponsors

Sponsors